DNY59
J.P. Morgan said its top biotech picks for 2025 were Vertex (NASDAQ:VRTX), Travere (NASDAQ:TVTX), SpringWorks (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT), Wave Life Sciences (NASDAQ:WVE), Xenon Pharmaceuticals (NASDAQ:XENE), Edgewise Therapeutics (NASDAQ:EWTX), Blueprint (NASDAQ:BPMC) and Roivant (NASDAQ:ROIV).
The investment bank said it could